Cancer continues to pose significant challenges to the medical community. Early detection,
accurate molecular profiling, and adequate assessment of treatment response are critical …

Aim: Liquid biopsies analyzing cell-free DNA (cfDNA) methylation in plasma offer a
noninvasive diagnostic for diseases, with the potential of aging biomarkers underexplored …

Cell-free DNA (cfDNA) from the bloodstream has been studied for cancer biomarker
discovery, and chromatin-derived epigenetic features have come into the spotlight for their …

The rapid development of medical technology and widespread application of
immunosuppressive drugs have improved the success rate of organ transplantation …

With the rapid development of science and technology, cell-free DNA (cfDNA) is rapidly
becoming an important biomarker for tumor diagnosis, monitoring and prognosis, and this …

Background Stool DNA test has been emerged as an effective noninvasive method for
colorectal cancer (CRC) screening, but the real‐world performance of stool DNA test in …

Background Pancreatic ductal adenocarcinoma (PDAC) is the digestive malignancy with
poor prognosis, and there is still a lack of effective diagnostic biomarkers. Objective We …

Simple Summary In dogs, hemangiosarcoma is the most common cancer of the spleen.
Although early diagnosis is effective for tumor control, benign and other malignant tumors …

Background Glioblastoma (GBM) is a malignant tumor with a short survival and poor
prognosis and a lack of clinically validated biomarkers for diagnosis and prognosis. Methods …

Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, usually
occurring in the background of chronic liver disease. HCC lethality rate is in the third highest …